[1] THANDRA K C,BARSOUK A,SAGINALA K,et al.Epidemiology of non-Hodgkin’s lymphoma[J].Med Sci(Basel),2021,9(1):5. [2] MANCUSO S,MATTANA M,SANTORO M,et al.Host-related factors and cancer:Malnutrition and non-Hodgkin lymphoma[J].Hematol Oncol,2022,40(3):320-331. [3] 张家瑛,刘景芳,顾霖,等.PG-SGA在血液肿瘤住院患者中的应用[C]//中国营养学会临床营养分会.第十四届全国临床营养学术会议资料汇编. 2014:196. [4] ZHANG Z,WAN Z,ZHU Y,et al.Prevalence of malnutrition comparing NRS2002,MUST,and PG-SGA with the GLIM criteria in adults with cancer:A multi-center study[J].Nutrition,2021(83):111072. [5] CHEN X,LIU X,JI W,et al.The PG-SGA outperforms the NRS2002 for nutritional risk screening in cancer patients:A retrospective study from China[J].Front Nutr,2023(10):1272420. [6] LANG J,SHAO Y,LIAO J,et al.Patient-Generated Subjective Global Assessment(PG-SGA)predicts length of hospital stay in lung adenocarcinoma patients[J].Br J Nutr,2022,127(10):1543-1548. [7] 何杰,王莉,徐卫.预后营养指数在恶性淋巴瘤患者中的预后价值[J].中国实验血液学杂志,2022,30(2):641-644. [8] 何华钰. 第一部分术前全身免疫炎症指数和预后营养指数在肺神经内分泌肿瘤患者术后生存中的预测价值分析第二部分肺原发性淋巴瘤的临床病理特征和预后影响因素分析[D].北京:北京协和医学院,2021. [9] 石英英,张晓伟,袁凯涛,等 .PG-SGA操作标准介绍[J].中华肿瘤防治杂志,2013,20(22):1779-1782. [10] WANG P,TAN Y,SOH K L,et al.Nutrition risk screening 2002 for adult cancer patients:A systematic review and meta-analysis[J].Nutr Cancer,2024,76(7):573-583. [11] 王莉,袁艳花,刘欣.NRS-2002与PG-SGA在中晚期肿瘤患者营养筛查及评估中的应用[J].海南医学,2024,35(2):210-214. [12] MENDES N P,BARROS T A,ROSA C O B,et al,Nutritional screening tools used and validated for cancer patients:A systematic review[J].Nutr Cancer,2019,71(6):898-907. [13] ZHANG L,WANG S,GAO X,et al.Poor pre-operative nutritional status is a risk factor of post-operative infections in patients with gastrointestinal cancer-a multicenter prospective cohort study[J].Front Nutr,2022(9):850063. [14] 郭会娜,岳翠翠.基于NRS2002系统的多学科营养支持在直肠癌放化疗患者中的应用效果[J].广州医药,2022,53(1):65-69. [15] 韦小婉,沈小卫,尚鹏,等.白细胞介素-21、β2微球蛋白、白蛋白水平与霍奇金淋巴瘤患者临床特征和预后的关系[J].癌症进展,2022,20(16):1690-1692,1696. [16] FENG C,YU H,LEI H,et al.A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer[J].BMC Palliat Care,2022,21(1):81. [17] HU X,FENG X,WANG H,et al.Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma:A single-center retrospective study[J].Transl Cancer Res,2023,12(6):1577-1587. [18] 杨梅,邓华聪.糖尿病与肿瘤关系研究进展[J].重庆医学,2013,42(6):700-702. [19] 张永芬,张艳艳.糖尿病合并多发性骨髓瘤患者化疗后感染的病原菌分布及其影响因素[J].中国卫生工程学,2023,22(5):657-659. [20] TEZCAN G,YAKAR N,HASTURK H,et al.Resolution of chronic inflammation and cancer[J].Periodontol 2000,2024,96(1):229-249. [21] PEDERSEN L M,KLAUSEN T W,DAVIDSEN U H,et al.Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma[J].Ann Hematol,2005,84(8):510-516. |